Role_of_postoperative_radiation_therapy_in_stage_IIIa_non-small_cell_lung_cancer._One_hundred_forty-six_patients_with_pathological_stage_IIIa_non-small_cell_lung_cancer_were_retrospectively_analyzed_to_determine_whether_postoperative_radiation_therapy_improves_survival_and_reduces_locoregional_recurrences._The_survival_rate_of_the_overall_group_at_1,_3,_and_5_years_was_56%,_24%,_and_17%,_respectively._Regarding_the_type_of_resection_and_histology,_we_did_not_observe_statistically_significant_differences._Patients_with_N0_and_N1_disease_were_grouped_and_compared_with_the_N2_group,_and_survival_at_3_and_5_years_was_41%_and_27%,_respectively,_for_the_T3_N0-1_group_and_17%_and_15%,_respectively,_for_the_T3_N2_group_(p_less_than_0.001_and_p_=_0.05,_respectively)._Eighty-six_patients_received_postoperative_irradiation_(45_to_50_Gy)_and_60_did_not._We_have_not_observed_any_improvement_in_survival_with_postoperative_radiation_therapy,_except_in_those_patients_with_N2_disease._Median_survival_time_was_6_months_for_patients_without_irradiation_and_15_months_for_those_with_irradiation_(p_=_0.071)._According_to_locoregional_recurrences,_a_slight_benefit_with_postoperative_radiation_therapy_was_observed.